McVicar William K. 4
4 · Salarius Pharmaceuticals, Inc. · Filed Sep 12, 2019
Insider Transaction Report
Form 4
McVicar William K.
President, R&D
Transactions
- Award
Stock Option (right to buy)
2019-09-10+3,000→ 3,000 totalExercise: $8.00From: 2019-12-31Exp: 2029-09-10→ Common Stock (3,000 underlying)
Footnotes (1)
- [F1]On July 19, 2019, the Issuer effected a 1-for-25 reverse stock split of its then outstanding common stock, resulting in the reporting person's ownership of 34,385 options.